153 related articles for article (PubMed ID: 10533819)
41. Proposed revised nomenclature for transfusion-related acute lung injury.
Toy P; Kleinman SH; Looney MR
Transfusion; 2017 Mar; 57(3):709-713. PubMed ID: 28019007
[TBL] [Abstract][Full Text] [Related]
42. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.
Rosse WF; Dacie JV
J Clin Invest; 1966 May; 45(5):736-48. PubMed ID: 5935361
[No Abstract] [Full Text] [Related]
43. The pathogenesis of transfusion-related acute lung injury (TRALI).
Bux J; Sachs UJ
Br J Haematol; 2007 Mar; 136(6):788-99. PubMed ID: 17341264
[TBL] [Abstract][Full Text] [Related]
44. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
45. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
46. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques.
van Stein D; Beckers EA; Peters AL; Porcelijn L; Middelburg RA; Lardy NM; van Rhenen DJ; Vlaar AP
Vox Sang; 2016 Jul; 111(1):71-8. PubMed ID: 26991993
[TBL] [Abstract][Full Text] [Related]
47. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
Porretti L; Coluccio E; Prati D; Colombo MB; Lopa R; Tombolini P; Ambrosone A; Crespiatico L; Scalamogna M; Rebulla P
Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
[TBL] [Abstract][Full Text] [Related]
48. Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury.
Fung YL; Kim M; Tabuchi A; Aslam R; Speck ER; Chow L; Kuebler WM; Freedman J; Semple JW
Blood; 2010 Oct; 116(16):3073-9. PubMed ID: 20616220
[TBL] [Abstract][Full Text] [Related]
49. Transfusion-related alloimmune neutropenia with no pulmonary complications: one donor-five cases.
Hauck-Dlimi B; Ruppel R; Zimmermann R; Strobel J; Reil A; Eckstein R; Zingsem J
Transfusion; 2016 Jan; 56(1):84-90. PubMed ID: 26388439
[TBL] [Abstract][Full Text] [Related]
50. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
Müller MC; van Stein D; Binnekade JM; van Rhenen DJ; Vlaar AP
Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
[TBL] [Abstract][Full Text] [Related]
51. Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test.
Nguyen XD; Flesch B; Sachs UJ; Kroll H; Klüter H; Müller-Steinhardt M
Transfusion; 2009 Dec; 49(12):2700-8. PubMed ID: 19659676
[TBL] [Abstract][Full Text] [Related]
52. Prevention of immune-mediated transfusion-related acute lung injury; from bloodbank to patient.
Műller MC; Porcelijn L; Vlaar AP
Curr Pharm Des; 2012; 18(22):3241-8. PubMed ID: 22621273
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
Fontaine MJ; Malone J; Mullins FM; Grumet FC
Ann Clin Lab Sci; 2006; 36(1):53-8. PubMed ID: 16501237
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
55. Immunophenotyping of Paroxysmal Nocturnal Hemoglobinuria (PNH).
Illingworth AJ; Marinov I; Sutherland DR
Methods Mol Biol; 2019; 2032():323-354. PubMed ID: 31522427
[TBL] [Abstract][Full Text] [Related]
56. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
57. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
58. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
[TBL] [Abstract][Full Text] [Related]
59. WBC alloimmunization: effects on the laboratory and clinical endpoints of therapeutic granulocyte transfusions.
Price TH; McCullough J; Strauss RG; Ness PM; Hamza TH; Harrison RW; Assmann SF
Transfusion; 2018 May; 58(5):1280-1288. PubMed ID: 29498050
[TBL] [Abstract][Full Text] [Related]
60. Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria.
Luzzatto L; Gianfaldoni G
Int J Hematol; 2006 Aug; 84(2):104-12. PubMed ID: 16926130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
